
Should You Scoop Up Shares of 23andMe?
Published on June 6, 2022
23andMe (ME) saw its shares slump in price after it reported its fourth-quarter earnings results last month. However, given the company's multiple FDA authorizations for over-the-counter genetic health risk reports,...
